Completed PHASE2 INTERVENTIONAL 6-arm NCT00373295

Effect of Baclofen on Marijuana Withdrawal and Relapse

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Baclofen Marijuana Placebo

Updated 7 times since 2017 Last updated: Mar 30, 2017 Started: May 31, 2006 Primary completion: Jan 31, 2008 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00373295, this PHASE2 trial focuses on Marijuana Dependence and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 7 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States